Michael Ross
Direktor/Vorstandsmitglied bei 20/20 GENESYSTEMS INC.
Aktive Positionen von Michael Ross
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| 20/20 GENESYSTEMS INC. | Direktor/Vorstandsmitglied | 01.07.2016 | - |
Havencrest Capital Management LLC
 Havencrest Capital Management LLC Investment ManagersFinance Havencrest Capital Management LLC (Havencrest Capital) is a private equity firm founded in 2017 by Christopher W. Kersey. The firm is headquartered in Dallas, Texas. | Private Equity Investor | 01.04.2020 | - |
LarreaRX, Inc.
 LarreaRX, Inc. Pharmaceuticals: MajorHealth Technology Part of Larrea Biosciences Corp., LarreaRX, Inc. produces and distributes dietary supplements, cold sore lotions, and penetrating sprays. The company is based in Casper, WY. The company was founded by David Timothy Kalenuik. LarreaRX was acquired by Larrea Biosciences Corp. on September 24, 2004. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Michael Ross
Ehemalige bekannte Positionen von Michael Ross
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| E-P Therapeutics, Inc. | Geschäftsführer | 01.06.2010 | 01.01.2015 |
| Präsident | 01.06.2010 | 01.01.2015 | |
CPL, Inc.
 CPL, Inc. Pharmaceuticals: MajorHealth Technology CPL, Inc. manufactures pharmaceutical ingredients. Its products include Alendronate Sodium, Amlodipine Besylate, Atomoxetine Hydrochloride, Bosentan, Celecoxib, Chlorhexidine Base and Desloratadine. The company was founded in 1999 and is headquartered in Washington, DC. | Präsident | 01.01.2007 | 01.10.2009 |
Euclid Vision Corp.
 Euclid Vision Corp. Medical SpecialtiesHealth Technology Euclid Systems Corp. provides eye care technology and services. It offers ophthalmic equipment, therapeutics, devices, and lenses. The company was founded in 1995 and is headquartered in Sterling, VA. | Private Equity Investor | - | - |
| Präsident | - | - | |
Euclid Vision Corp.
Euclid Vision Corp. Medical SpecialtiesHealth Technology Euclid Systems Corp. provides eye care technology and services. It offers ophthalmic equipment, therapeutics, devices, and lenses. The company was founded in 1995 and is headquartered in Sterling, VA. | Vorstandsvorsitzender | 31.12.2012 | - |
| Vorsitzender | 10.02.2015 | - | |
| Corporate Officer/Principal | 25.06.2012 | 31.12.2012 | |
| Präsident | 31.12.2012 | - |
Ausbildung von Michael Ross
| George Washington University School of Medicine & Health | Doctorate Degree |
| Dickinson College | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 9 |
Operativ
| President | 4 |
| Director/Board Member | 2 |
| Private Equity Investor | 2 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Euclid Vision Corp.
Euclid Vision Corp. Medical SpecialtiesHealth Technology Euclid Systems Corp. provides eye care technology and services. It offers ophthalmic equipment, therapeutics, devices, and lenses. The company was founded in 1995 and is headquartered in Sterling, VA. | Health Technology |
20/20 GeneSystems, Inc.
 20/20 GeneSystems, Inc. Medical/Nursing ServicesHealth Services 20/20 GeneSystems, Inc. develops and commercializes proteomics product line. Its products include One Test, PAULA's Test and BioCheck Suspisious Powder Testing Kit. The company was founded by Jonathan Cohen in 2000 and is headquartered in Rockville, MD. | Health Services |
Havencrest Capital Management LLC
Havencrest Capital Management LLC Investment ManagersFinance Havencrest Capital Management LLC (Havencrest Capital) is a private equity firm founded in 2017 by Christopher W. Kersey. The firm is headquartered in Dallas, Texas. | Finance |
LarreaRX, Inc.
LarreaRX, Inc. Pharmaceuticals: MajorHealth Technology Part of Larrea Biosciences Corp., LarreaRX, Inc. produces and distributes dietary supplements, cold sore lotions, and penetrating sprays. The company is based in Casper, WY. The company was founded by David Timothy Kalenuik. LarreaRX was acquired by Larrea Biosciences Corp. on September 24, 2004. | Health Technology |
| E-P Therapeutics, Inc. | |
CPL, Inc.
CPL, Inc. Pharmaceuticals: MajorHealth Technology CPL, Inc. manufactures pharmaceutical ingredients. Its products include Alendronate Sodium, Amlodipine Besylate, Atomoxetine Hydrochloride, Bosentan, Celecoxib, Chlorhexidine Base and Desloratadine. The company was founded in 1999 and is headquartered in Washington, DC. | Health Technology |
- Börse
- Insiders
- Michael Ross
- Erfahrung